• Philippines

• Philippines

The Philippines is missing more than 41% of its 573,000 people estimated to have developed drug-sensitive TB in 2016. During the same year, more than 82% of its 30,000 people estimated to have developed drug-resistant TB were also missed by the health system.

To find more of its missing people with TB, the Philippines is implementing a three-throng approach. The country is planning to procure 280 GeneXpert/Omni machines for rural health units, health centers and DOTS facilities across the country, as a way to optimize the utilization of the GeneXpert MTB/RIF. This move will support the transition from smear microscopy to GeneXpert as the primary diagnostic tool for TB in the Philippines. The country is also expanding systematic screening of high-risk groups, notably through systematically screening congregate settings, urban poor and contacts in sites with a high population/TB burden. Moreover, engagement of private health care providers is being strengthened, particularly through engaging stand-alone physicians and those affiliated with hospitals, along enforcing compliance with the mandatory TB case notification policy of the Philippines.